Rep. Gilbert Ray Cisneros, Jr. Sells Eli Lilly Shares

Congressman discloses sale of $1,001 to $15,000 in Eli Lilly stock

Apr. 10, 2026 at 3:08am

Got story updates? Submit your updates here. ›

An extreme close-up of intricately detailed industrial machinery, cogs, and levers in shades of silver, black, and chrome, conceptually representing the complex financial infrastructure of a major pharmaceutical company.A close examination of the inner workings of a pharmaceutical giant reveals the complex financial machinery behind its public face.Indianapolis Today

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of pharmaceutical giant Eli Lilly and Company (NYSE:LLY). In a filing disclosed on April 7th, the Congressman reported selling between $1,001 and $15,000 worth of Eli Lilly stock on March 13th.

Why it matters

As a member of Congress, Cisneros is subject to strict financial disclosure rules. His sale of Eli Lilly shares provides a window into the investment activities of federal lawmakers, which can raise questions about potential conflicts of interest or insider trading.

The details

Cisneros, who represents California's 31st Congressional District, has served in the U.S. House of Representatives since 2025. Prior to entering politics, he had a career in the Navy and worked as a logistics manager. In 2010, Cisneros won the lottery and became involved in activism and philanthropy.

  • Cisneros disclosed the stock sale on April 7, 2026.
  • The sale of Eli Lilly shares occurred on March 13, 2026.

The players

Gilbert Ray Cisneros, Jr.

A Democratic member of the U.S. House of Representatives, representing California's 31st Congressional District since 2025.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly researches, develops, manufactures and commercializes a broad range of medicines and therapies.

Got photos? Submit your photos here. ›

What’s next

The House Ethics Committee may review the stock sale to ensure Cisneros complied with all applicable rules and regulations.

The takeaway

This transaction highlights the ongoing scrutiny over the financial activities of members of Congress and the need for robust disclosure requirements to maintain public trust in the political process.